BC, OCN, explained that comprehensive disease and treatment education are essential to adherence for patients with breast ...

Experts discuss treatment options for HER2-positive metastatic breast cancer following progression on trastuzumab deruxtecan (T-DXd), weighing real-world data on tucatinib-capecitabine-trastuzumab ...

Experts discuss how, discuss patient experiences with an oral chemotherapy regimen, highlighting benefits like treatment autonomy, challenges such as pill burden and gastrointestinal toxicities, and ...

Seth Eisenberg, ASN, RN, OCN, BMTCN, explained his research on a toilet cover for oncology nurses to potentially reduce ...

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality ...

Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

Video content above is prompted by the following: • What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize ...